Lisinopril And Hydrochlorothiazide
Product Images NDC 66336-572

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 66336-572). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0572-xx (Ndc 66336 0572 Xx Lupin)

Ndc 66336-0572-xx (Ndc 66336 0572 Xx     Lupin)
This is the information of a bulk source data of Lisinopril/hctz 10mg/12.5mg medication containing XX tablets in a bottle, with NDC 66336-0572-XX and product #646-XX. The tablet is blue, hexagonal and has an LL/801 imprint. It should be dispensed in a light-resistant container and taken orally at a specified interval. The medication can cause dizziness, lightheadedness, and sensitivity to sunlight, and it is not recommended for pregnant women. It must be stored at controlled room temperature. The manufacturer is Lupin Pharmaceuticals in Baltimore, MD; however, the bulk source is unknown. It was packaged exclusively by SolutionG? in Santa Ana, CA.*
FDA Label Image

Lisinopril Usp (Lisiniprilhctz Figure 01)

FDA Label Image

Hctz Usp (Lisiniprilhctz Figure 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.